This study, through technical means such as cell and animal experiments, for the first time clarified that fluoxetine combined with Longya Lily exerts a therapeutic effect on depression by regulating inflammatory response through the COX-2/PGE2/IL-22 axis. Here, IL22 is linked to major depressive disorder.